1018 - Outcomes in Intravenous to Oral Antimicrobial Therapy in Uncomplicated Beta-hemolytic Streptococcus Bloodstream Infections in Immunocompromised Individuals

Thursday, October 12, 2023

4:15 PM – 4:30 PM US ET

Location: 204 AB

Presenting Author(s)

Mackenzie R. Keintz, MD (she/her/hers)

Fellow
University of Nebraska Medical Center
Omaha, NE, United States

Slides

Co-Author(s)

CT

Cristina J. Torres, MD (she/her/hers)

ID Fellow, House Officer IV
University of Nebraska Medical Center
Papillion, Nebraska, United States
Molly M. Miller, PharmD, BCIDP

Clinical Pharmacist Practitioner
Nebraska Medicine
Omaha, Nebraska, United States
Bryan T. Alexander, PharmD, BCIDP, AAHIVP

Pharmacy Coordinator
Nebraska Medicine
Omaha, Nebraska, United States
EL

Elizabeth Lyden, MS

Associate Director, Center for Collaboration on Research, Design and Analysis
University of Nebraska Medical Center
Omaha, Nebraska, United States
JM

Jihyun Ma, MS

Statistician
University of Nebraska Medical Center
Omaha, Nebraska, United States
Erica J. Stohs, MD, MPH (she/her/hers)

Assistant Professor
University of Nebraska Medical Center
Omaha, NE, United States
Trevor C. Van Schooneveld, MD, FSHEA, FACP

Professor, Division of Infectious Diseases
University of Nebraska Medical Center
Omaha, NE, United States
Jasmine R. Marcelin, MD (she/her/hers)

Associate Professor of Medicine
University of Nebraska Medical Center
Omaha, NE, United States

Disclosure(s):

Erica J. Stohs, MD, MPH: bioMerieux: Grant/Research Support (Ongoing); Merck: Grant/Research Support (Ongoing)

Trevor C. Van Schooneveld, MD: AN2 Therapeutics: Grant/Research Support (); Biomeriuex: Advisor/Consultant (), Grant/Research Support (); Insmed: Grant/Research Support (); Thermo-Fischer: Honoraria ()